Macquarie Park, Australia · Founded 2022 · Privately Held (backing)
Developer of neurotherapeutic interventions designed for treatment-resistant neurodegenerative conditions. Celosia Therapeutics is based in Macquarie Park, Australia and was founded in 2022. It has raised $18.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$18.8M
Last round
—
Cap table — not yet on record
Celosia Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Celosia Therapeutics with a free account
·Watch Celosia Therapeutics: the Monday email on marks, rounds and moves
